| Financial Year |
March 31 2023 |
| Monetary Funds |
1,864,512,220.00 |
| Held-for-trading Financial Assets |
367,321,211.00 |
| Notes Receivable |
221,463,629.00 |
| Accounts Receivable |
1,125,315,956.00 |
| Advances to Suppliers |
354,926,409.00 |
| Other Receivables |
204,160,107.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,921,966,975.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
223,232,953.00 |
| Total Current Assets |
10,559,091,414.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,283,076.00 |
| Long-term Equity Investment |
3,771,534,936.00 |
| Investment Properties |
1,138,421,219.00 |
| Fixed Assetes |
1,431,825,818.00 |
| Under-construction Projects |
57,346,440.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,015,716,683.00 |
| R&D expenses |
15,571,063.00 |
| Goodwill |
6,227,677.00 |
| Long-Term Deferred and Prepaid Expenses |
41,630,006.00 |
| Deferred Income Tax Assets |
213,631,803.00 |
| Other Non-Current Assets |
50,000,000.00 |
| Sub-Total of Non-Current Assets |
7,847,983,728.00 |
| Total Assets |
18,407,075,142.00 |
| Short-Term Loans |
15,338,600.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
662,332,276.00 |
| Accounts Payable |
1,217,975,826.00 |
| Accounts Received In Advance |
27,524,790.00 |
| Employee Compensation Payable |
116,083,110.00 |
| Taxes Payable |
82,484,366.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
250,267,116.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,657,807.00 |
| Other Current Liabilities |
18,216,631.00 |
| Sub-Total of Current Liabilities |
7,177,565,978.00 |
| Long-term Loans |
750,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
37,283,375.00 |
| Deferred Income Tax Liabilities |
304,973,536.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,879,208,380.00 |
| Total Liabilities |
9,056,774,358.00 |
| Paid-In Capital(Or Share Stock) |
1,223,372,955.00 |
| Capital Surplus |
995,802,803.00 |
| Surplus Reserve |
1,408,952,714.00 |
| LESS:Treasury Stock |
222,934,975.00 |
| Undistributed Profits |
5,967,291,171.00 |
| Minority Stockholder's Interest |
70,042,919.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,280,257,865.00 |
| Owner's Equity（Stockholder's Equity） |
9,350,300,784.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,407,075,142.00 |
